gIcare Pharma

gIcare receives $7M series A financing

Monday, August 1, 2011

gIcare Pharma has closed a $7 million Series A financing round to develop a novel alternative to perform safe, painless colonoscopies without sedation. In addition to offering clinical benefits during the procedure, GIC-1001’s use does not require a recovery room or particular medical assistance post-colonoscopy. This colonic analgesic approach aligns well with the current global strategy to reduce healthcare costs.

[Read More]